Glaukos Corp. (GKOS)
116.21
-0.43
(-0.37%)
USD |
NYSE |
Dec 26, 16:00
116.23
+0.02
(+0.02%)
Pre-Market: 20:00
Glaukos EPS Diluted (Quarterly): -0.2828 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.23M |
| Revenue (Quarterly) | 133.54M |
| Total Expenses (Quarterly) | 149.77M |
| Enterprise Value | 6.505B |
| Gross Profit Margin (Quarterly) | 78.41% |
| Profit Margin (Quarterly) | -12.15% |
| Earnings Yield | -1.33% |
| Normalized Earnings Yield | -1.335 |